Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 61-70 of 223 for

Edit search filters
  1. Healthcare Worker Exposure Response And Outcomes Of Hydroxychloroquine

    Rochester, MN

  2. Evaluation Of De-escalated Adjuvant Radiation Therapy For Human Papillomavirus (HPV)-Associated Oropharynx Cancer

    Albert Lea, MN, Scottsdale/Phoenix, AZ, Eau Claire, WI, La Crosse, WI, Mankato, MN, Rochester, MN

  3. Safety And Efficacy Of SA4Ag Vaccine In Adults Having Elective Open Posterior Spinal Fusion Procedures With Multilevel Instrumentation

    Rochester, MN

  4. A Multicenter Treatment Protocol Of Daclatasvir (BMS-790052) In Combination With Sofosbuvir For The Treatment Of Post-Liver Transplant Subjects With Chronic Hepatitis C

    Scottsdale/Phoenix, AZ

  5. Acupuncture Therapy for COVID-Related Olfactory Loss

    Rochester, MN

  6. Evaluation Of The Efficacy And Safety Of Sarilumab In Hospitalized Patients With COVID-19 (Enrollment By Invitation Only)

    Rochester, MN

  7. A Study Comparing The Effectiveness And Safety Of High-Titer Versus Low-Titer Anti-Influenza Immune Plasma For The Treatment Of Severe Influenza A

    Rochester, MN

  8. An Expanded Access Study Of Sofosbuvir Combined With Ribavirin And Either With Or Without Pegylated Interferon For Treating Aggressive Post-Transplant Hepatitis C

    Jacksonville, FL

  9. Ledipasvir/Sofosbuvir Fixed-Dose Combination + Ribavirin In Subjects With Chronic HCV With Advanced Liver Disease Or Post-Liver Transplant

    Jacksonville, FL

  10. Presatovir In Hematopoietic Cell Transplant Recipients With Respiratory Syncytial Virus Infection Of The Upper Respiratory Tract

    Scottsdale/Phoenix, AZ

.

Mayo Clinic Footer